Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.7B | 5.2B | 5.0B |
Cost of revenue | 2.3B | 2.7B | 2.4B | 2.4B |
Gross profit | 2.7B | 3.0B | 2.9B | 2.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.9B | 2.0B | 1.8B | 1.8B |
Other operating expenses | 306M | 351M | 293M | 214M |
Operating income | 501M | 664M | 766M | 623M |
Non operating interest income | ||||
Income | 3M | 7M | 8M | 5M |
Expense | 80M | 65M | 54M | 48M |
Other income expense | — | — | — | — |
Pretax income | 439M | 595M | 724M | 550M |
Tax provision | 107M | 145M | 147M | 107M |
Net income | 332M | 450M | 577M | 443M |
Basic EPS | 180.0 | — | 312.1 | 239.3 |
Diluted EPS | 180.0 | — | 312.0 | 239.3 |
Basic average shares | 1.9M | — | 1.9M | 1.9M |
Diluted average shares | 1.9M | — | 1.9M | 1.9M |
EBITDA | 1.0B | 1.1B | 1.2B | 1.0B |
Net income from continuing op. | 439M | 595M | 724M | 550M |
Minority interests | 2M | -2M | 2M | 1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |